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INTRODUCTION 
Asthma is a heterogeneous disease characterized by 
chronic airway inflammation. It is identified by 
history of respiratory symptoms such as wheezes, 
shortness of breath, chest tightness and cough that 
differ over time and in intensity, together with 
variable expiratory airflow limitation.1 Many trials 
have been done to classify asthmatics into different 
phenotypes that might predict disease sequence and 
treatment response.2 
 
Obesity among children has been increased 
significantly in the last few years. It is defined as a 
body mass index (BMI) at or above the 95th 
percentile for children of the same age and gender.3 
In recent years, the incidences of obesity and 
asthma have been rising with a parallel relationship. 
Obese asthma phenotype is supposed to be non-T 
helper type 2 (Th2) mediated in which low 
fractional exhaled nitric oxide, eosinophils and IgE 
levels were detected.4 
Original article 
Background: Asthma is an airway inflammatory disorder with functional 
and structural changes. Regulatory T (T reg) cells are important in 
controlling immune responses. The study was aimed to investigate the 
frequency of Treg cells in obese asthmatic children, in comparison to non-
obese asthmatics and healthy matched controls . 
Methods: In addition to anthropometric and body mass index (BMI) 
assessment, peripheral blood samples from healthy control subjects (n = 30) 
and asthmatic obese (n=30) and asthmatic non-obese children (n=30) were 
examined for serum IgE, eosinophils counts, and flowcytometric 
measurement of CD4+CD25+CD127 low/neg- T cells. Pulmonary function 
testing was performed for asthmatic children . 
Results: Obese asthmatics showed significantly higher levels of serum IgE 
and CD4+CD25+CD127 low/neg- T cells as compared to healthy controls 
(p<0.001, 0.001, respectively) while comparable numbers  of T reg cells 
were found among obese and non-obese asthmatic children. Asthmatics 
receiving inhaled corticosteroids (ICS) showed higher percentages of 
CD4+CD25+CD127 low/neg- T cells than the non-receivers (median 11.8% 
vs 8.8%, p <0.001). No significant correlations were found between Treg 
and age, eosinophil percentage, total serum IgE, pulmonary functions, or 
BMI and its Z score . 
Conclusion: Our study demonstrates an increased frequency of Treg cells in 
asthmatic children compared to controls with possible association with the 
use of ICS but not with obesity. Small sample size and lack of obese non-
asthmatic group are the main points of limitation in our study. 
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In allergic diseases, the current concept suggests 
that inadequate Treg cell suppression of effector 
cells or diminished Treg cell numbers contributes to 
the development of allergic inflammation. The 
mechanisms underlying the association between 
obesity and asthma might be related to a decreased 
immunological tolerance induced by a defective 
function of Tregs.5 
The frequency and significance of Treg cells in 
allergic obese and non-obese asthmatics remains 
poorly defined, especially in children where the 
initiation of allergic asthma most often occurs. 
Previously published studies analyzing human Treg 
cells have utilized several phenotypic markers 
including CD25, CD127, and Foxp3.6 
In this study, we used multi-parameter flow 
cytometry to investigate the frequency of Treg cells 
(CD4+ CD25+ CD127 low/neg- T cells) in the 
peripheral blood of obese and non-obese asthmatic 
children, compared to healthy matched controls. 
The frequency of Treg cells was further analyzed in 





This is a controlled cross-sectional study involving 
60 asthmatic cases (30 obese and 30 non-obese) and 
30 healthy age and gender matched controls, with 
age ranging between 6 to 18 years. They were 
recruited from the Outpatient Clinic of Allergy, 
Respiratory and Clinical immunology unit of 
Mansoura University Children’s Hospital (MUCH) 
during the period between February 2016 and 
February 2018. Bronchial asthma was diagnosed 
according to guidelines of Global Initiative for 
Asthma Management and Prevention (GINA 
2016).7 Obesity was defined as having BMI at or 
above the 95th percentile for children of the same 
age and gender.3 Asthmatic patients with co-
morbidities such as chronic cardiopulmonary 
disease, concurrent pneumonia or nasal polyps were 
excluded from the study. Also, patients on allergen 
immunotherapy protocols or those receiving 
systemic steroids were excluded from the study due 
to possible effects on the T reg cells population. 8 
All patients’ samples were obtained in accordance 
with the Declaration of Helsinki, with informed 
consent from parents/ caregivers of enrolled cases. 
The study was approved from Faculty of Medicine-
Mansoura University Institutional Review Board 
(IRB) with the code number MS/16.01.45. 
 
 
   
Methods 
Enrolled subjects were subjected to the following 
clinical and laboratory evaluation: 
 
Detailed clinical history taking and general and 
systematic examination. Patient’s data included 
age, sex, residence, parental consanguinity, family 
history of bronchial asthma, associated allergic 
rhinitis, atopic dermatitis, allergic march, exposure 
to trigger, nutritional history and dietetic history. 
Asthma severity and control were assessed 
according to GINA, 2016.7  
Physical examination included measurement of 
height and weight for calculation of body mass 
index (BMI = weight (Kg)/ height (m)2). Age- and 
sex-specific Z-score for BMI [standard deviation 
scores (SDS)] using Egyptian children and 
adolescents’ reference data are calculated by the 
following equation: 9  
Z-score = (observed value)-(median reference value 
of a population) / SD of reference population 
 
Pulmonary function tests (PFTs):  
The top of three successive measurements of forced 
expiratory volume 1(FEV1) was measured by a 
spirometer Spiro bank II (Roma, Italy). Reference 
standards were computed according to American 
Thoracic Society (ATS) of Acceptability and 
Reproducibility.10 
 
Blood Collection and laboratory investigations 
Peripheral blood (PB) samples were collected from 
patients and healthy controls and used as follows: 
Blood samples collected in plain tubes were used 
for measuring total serum IgE in serum by 
immunoassay techniques, by using IgE ELISA 
KITS from Aptech Services, following the 
manufacturer’s instructions. 
Blood samples collected in Ethylene diamine 
tetra acetic acid (EDTA) tube were used for 
measuring complete blood counts, automatically 
performed by Coulter LH 750 cell counter (Coulter, 
Electronics, Hialeah, FL, USA) then peripheral 
blood smears were stained with Leishman stain for 
manual differential white cell counts with special 
emphasis on eosinophils relative counts (EOS %).  
 
Flow Cytometry, Antibodies, and Staining  
Fresh EDTA samples were used also for evaluation 
of Treg cells (CD4+ CD25+ CD127 low/- T cells). 
Cells were stained with appropriate monoclonal 
antibodies (anti CD 4 phycoerythrin (PE), anti-
CD25 PE-CY7-A and anti-CD127 fluorescein 
isothiocyanate (FITC) (Beckman Coulter, Kraemer 
Blvd. Brea, CA 92821 U.S.A.). They were used at 
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concentration recommended by their manufacturers. 
Cells were acquired on FACS CantoII (BD 
Biosciences). Data were analyzed using FACS 
DIVA software. A gate was drawn around the 
population of interest: CD4+ cells. The gate on 
double positive CD4+ CD25+ cells was set. 
Analysis of the fluorescence data from events in 
this gate was then performed to determine the 
CD127 low/neg-.  
 
Statistical methods: SPSS software package 
version 22.0 was used to analyze the data.  
Qualitative data were represented as number and 
percent. Quantitative data were represented as range 
(minimum and maximum), mean, standard 
deviation and median. The used tests were paired t-
test, Chi-square test, Kruskal-Wallis test, One Way 
ANOVA, and Mann Whitney test to match the 





The Mean age was 9.87±2.52, 9.63±2.89 and 
9.87±0.73 years and male represented 66.7 %, 70 % 
and 60 % among asthmatic obese, asthmatic non-
obese and healthy control groups, respectively, with 
comparable results between the three groups 
(F=0.079, p=0.924; χ2=2.34, p=0.31) . 
 
Characteristics of asthma among obese and non-
obese patients . 
The mean duration of asthma was 7.7±1.97 and 
6.2±1.56 years among the obese and non-obese 
asthmatics, respectively (t=3.27, p=0.002), with 
longer asthma duration among the obese group 
despite comparable ages. No significant difference 
was observed between both groups as regard the 
frequency of associated allergic rhinitis and atopic 
dermatitis (χ2=1.09, 0.88 and p=0.29, 0.35, 
respectively). Moderate persistent asthma was 
detected in 63.3% of asthmatic obese group and in 
30% in asthmatic non-obese group (χ2=6.69, p= 
0.01). None of the participants had severe asthma. 
Controlled asthma comprised 60% of the obese 
cases versus 83.3% of the non-obese asthmatics 
(χ2=4.02, p= 0.04). ICS represented the commonest 
controller medication for persistent asthma among 
our patients, used in 73.4% among obese and 53.3% 
among the non-obese asthmatics . 
Comparison between obese and non-obese 
asthmatics in terms of their clinical characteristics, 
asthma severity, asthma control and controller 
medications are shown in table 1. 
 
Laboratory findings among the studied groups : 
Total serum IgE levels were significantly higher in 
both asthmatic obese and non-obese groups 
compared to healthy non-obese control group 
(p<0.001), while eosinophil relative counts were 
comparable among the three studied groups 
(F=1.07, p=0.34) (table 2) . 
 
Peripheral blood (PB) Treg cell frequency 
among the studied groups 
In our study, analysis of PB revealed a significantly 
higher percentage of CD4+CD25+CD127 low/neg-
T cells, in both asthmatic obese and non-obese 
groups compared to healthy controls (p< 0.001). No 
significant difference was noted in 
CD4+CD25+CD127 low/neg- T cells percentages 
between obese and non-obese asthmatics (p=0.75) 
(Table 2) . 
 
The correlation between Treg and the clinical 
and laboratory data of asthmatic children 
Our analysis revealed significant positive 
correlation between T reg and degree of asthma 
severity and asthma uncontrol (r= 0.418, 0.292, p= 
0.001, 0.02, respectively). No significant 
correlation was found between Treg and age, 
eosinophil counts, total serum IgE levels, 
pulmonary functions parameters, BMI, and its Z 
score (table 3) . 
 
The relation between T reg cells and ICS 
treatment  
T reg percentages were significantly higher 
(Z=10.98, p <0.001) in patients on ICS treatment 
[median (range): 11.8 (5.3-18.2)] versus those who 
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Duration of illness (years) 
7.70±1.97 6.2±1.56 
t=3.27 
p=0.002 Mean ± SD 
 N % N %  
Degree of asthma severity 
Mild Persistent 11 36.7 21 70 χ2=6.69 
p=0.01 Moderate persistent 19 63.3 9 30 
Associated atopic dermatitis 
Positive 5 16.7 8 26.7 χ2=0.88 
p=0.35 Negative 25 83.3 22 73.3 
Associated allergic rhinitis 
Positive 19 63.3 15 50 χ2=1.09 
p=0.29 Negative 11 36.7 15 50 
History of controller medications 
ICS 5 16.7 1 3.3 
χ2=4.43 
p=0.11 
ICS & leukotriene modifier 17 56.7 15 50 
Leukotriene modifier 8 26.7 14 46.7 
Level of asthma control 
Controlled 18 60 25 83.3 χ2=4.02 
p=0.04 Partially controlled 12 40 5 16.7 
ICS: inhaled corticosteroids; N: number of subjects; SD: standard deviation; t: student t – test; χ2: Chi square test 
 
 


































































Data is presented as median and range. 
BMI: body mass index; F: One Way ANOVA; IgE: Immunoglobulin E; KW: Kruskal-Wallis test. n: number of subjects; SD: 
Standard Deviation 
p1: difference between asthmatic obese and asthmatic non-obese, 
p2: difference between asthmatic obese and healthy control, 
p3: difference between asthmatic non-obese asthmatics and healthy controls 
 


















T reg % 
r -0.097 -0.064 -0.055 0.027 0.181 0.146 0.029 0.418 0.292 
p 0.46 0.62 0.67 0.83 0.17 0.26 0.82 0.001 0.024 
BMI: body mass index; FEV1: forced expiratory volume in first second; FVC: forced vital capacity; IgE: Immunoglobulin E; 
r=Spearman's rank correlation; L: liter; Ls: Liter per second; p=probability 
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DISCUSSION 
Asthma is one of the main reasons of chronic 
morbidity and mortality in the world. There is 
evidence that asthma prevalence has increased in 
the last 20 years.11 In Egypt, prevalence of 
childhood was found to be 7.7% in the Delta 
region.12 Obesity and asthma are the most common 
chronic morbidities in children in the developing 
and developed regions.13 
The current study was conducted to evaluate T 
regulatory cells  among obese asthmatic children in 
relation to their clinical characteristics including 
pulmonary functions, controller medications, 
inflammatory biomarkers (total serum IgE, 
peripheral eosinophil percentages) and in 
comparison to non-obese asthmatic and healthy 
matched controls.  
In the current study, asthmatic children, whether 
obese or non-obese, had higher percentages of T reg 
cells CD4+CD25+CD127 low/neg- T cells 
compared to the healthy controls. T regulatory cells 
and its secreted anti-inflammatory cytokine IL-10 
are essential to control the abnormally Th2 driven 
immune response in asthma, aiming to maintain the 
immune response within the normal range.14 
Studies investigating the levels of these cells in 
asthmatic children have contradictory results. 
Concordant with our results, Smyth et al reported 
increased T reg cell counts in the bronchoalveolar 
lavage fluid (BALF) of asthmatic patients in 
comparison to healthy controls, with higher T reg 
cell counts among patients with moderate to severe 
versus those with mild asthma.15  Worth to note that 
in our study, Tregs correlated positively with 
asthma severity and the degree of asthma uncontrol. 
Some relevant studies reported similar findings.16-18 
On the other hand, Hartl et al, reported lower 
levels of T reg cells together with their impaired 
function in the BALF of asthmatic children 
compared with values in matched controls, 
abnormalities that were reversed with the use of 
ICS. 19 Also, Yang et al who investigated 150 
asthmatic children, noticed significantly lower Treg 
cell counts with significantly lower Th1/Th2 ratio 
in the asthma group. The authors also reported 
negative correlation between the Treg cell counts 
and the severity of asthma, suggesting important 
role of Treg in pathogenesis of asthma.20 Their 
findings were also reported by other investigators.21-
23  
Different results between our study and the 
others might be attributed to several factors 
including different study designs and methods of 
evaluation of T reg cells whether using CD4+ 
CD25+ only, CD4+ CD25+ FOXP3+ or 
CD4+CD25+CD127 low/neg-Tcells. Also, we have 
no data about the baseline levels of T reg cells 
among the studied patients and demonstrating the 
changes in these levels with disease exacerbation 
might have provided clearer conclusions. We have 
no information about the patients’ vitamin D status 
at enrollment and our patients were not steroid 
naive as well, and all of them were on controller 
medications at enrolment, and their dosing were not 
considered in the statistical analysis. All these 
factors in addition to the different sample sizes 
might explain the different study results. 
In our patients, T reg cells percentages were 
significantly higher among patients on ICS versus 
those who were not. Singh et al, showed increasing 
Treg cell counts in asthmatic children that was 
related to ICS, and not severity of asthma, allergic 
sensitization, or the presence of atopy.6  
Interestingly, an Egyptian study reported 
significantly increased expression of FOXP3 in 
asthmatic children on corticosteroids (either inhaled 
or systemic) in comparison to steroid naive 
asthmatics, confirming the promoting effect of 
corticosteroids on suppressive T reg cells, adding to 
the ICS anti-inflammatory effect.24 In contrast to 
our study, Moniuszko et al, showed no significant 
difference in Treg cells between asthmatic patients 
with inhaled corticosteroids compared to steroid-
naive patients groups.25 
The role of corticosteroids was postulated to 
shift the balance of adaptive immune responses 
toward Treg cell predominance.6 Also, it was 
reported that in vitro glucocorticoids induced 
FOXP3 expression in CD4+T cells. Karagiannidis 
et al reported that asthmatic patients receiving 
glucocorticoids had higher levels of Tregs and 
FOXP3 mRNA expression in peripheral blood 
compared with levels seen in untreated asthmatic 
patients.26 
Obesity increases the incidence of asthma by 2.0 
folds in children and obese asthmatic patients are 
often described as severe and poorly controlled. 
Several factors are implicated including 
physiological and anatomical factors, decreased 
response to corticosteroids and the association of 
obesity with chronic low-grade systemic 
inflammation that is thought to enhance systemic 
complications. The association between obesity and 
asthma severity was also proposed to be related to 
decreased immunological tolerance induced by a 
defective function of Tregs in obese individuals. 
Improper clearance of apoptotic cells might 
contribute to development and progression of 
chronic inflammatory diseases such as asthma.27 In 
our study, the obese asthmatic group showed higher 
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frequencies of moderate and partially uncontrolled 
asthma in comparison to the non-obese asthmatics. 
However, we could not find a significant difference 
between obese and non-obese asthmatic children in 
terms of the T reg cells percentages. There is some 
evidence on the anti-inflammatory role exerted by 
Treg cells in obesity via release of IL-10 aiming to 
suppress obesity-induced inflammation. On the 
other hand, high insulin levels in obesity has been 
suggested to exert an inflammatory role by 
decreasing IL-10 production and impairing Treg 
cell-induced suppression, owing to insulin receptors 
on T reg cells.28 Treg cells are decreased in both 
obese mice and humans.29 Furthermore, 
Adiponectin reduction has been observed in obese 
asthmatic children which is thought to be 
responsible for a diminished release of IL-10 by 
Treg cells, impairing the function of these cells and 
thus worsening the pro-inflammatory status.30 In 
our work, asthmatic patients were on ICS and we 
did not measure IL-10 production or other anti- and 
pro inflammatory cytokines, which comprise 
limiting factors to our results and might have 
masked possible T reg cell abnormalities expected 
to be observed in obese subjects.  
In contrast to our results, a study performed on 
160 children comparing (40 obese, 40 asthmatic, 40 
obese asthmatic, and 40 healthy controls) showed 
lower frequencies of Treg cells in obese, asthmatic 
and obese asthmatic children than normal 
controls.31 This is while, in another study that 
investigated asthmatic patients (12 obese and 10 
non obese), the authors could not demonstrate a 
significant difference in Tregs counts between 
obese and control groups.32  
We did not find significant associations between 
IgE levels and eosinophil percentage and Treg cells, 
results that are matching to those reported by Hartl  
et al. 19 We did not perform skin prick test to verify 
the atopic status of our studied patients, which is 
another limiting factor to our results. 
In conclusion, our study demonstrates increased 
frequency of Treg cells in the peripheral blood of 
asthmatic obese and non-obese children compared 
to healthy controls. T reg cells percentages are also 
associated with the degree of asthma severity, and 
uncontrol with possible impact of ICS treatment on 
T reg cells. Added to the aforementioned factors, 
our findings are limited by small sample size, lack 
of obese non-asthmatic group, lack of baseline data 
and atopy verification, broad age range of enrolled 
subjects, non-consideration of the lifestyle, type of 
diet,  exercising, muscle mass and vitamin D status; 
factors that warrant wider scale longitudinal studies 
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